Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1959 Jun 27;1(5138):1610–1614. doi: 10.1136/bmj.1.5138.1610

Chemotherapy of Pulmonary Tuberculosis*

John Crofton
PMCID: PMC1993570  PMID: 13662631

Full text

PDF
1610

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CROFTON J. Sputkm conversion and the metabolism of isoniazid. Am Rev Tuberc. 1958 May;77(5):869–871. doi: 10.1164/artpd.1958.77.5.869. [DOI] [PubMed] [Google Scholar]
  2. FOX W., WIENER A., MITCHISON D. A., SELKON J. B., SUTHERLAND I. The prevalence of drug-resistant tubercle bacilli in untreated patients with pulmonary tuberculosis; a national survey, 1955-56. Tubercle. 1957 Apr;38(2):71–84. doi: 10.1016/s0041-3879(57)80001-4. [DOI] [PubMed] [Google Scholar]
  3. MACGREGOR A. R., STEWART S. M., TURNBULL F. W. The influence of chemotherapy on the bacterial content of tuberculous pulmonary lesions. Tubercle. 1956 Dec;37(6):388–403. doi: 10.1016/s0041-3879(56)80183-9. [DOI] [PubMed] [Google Scholar]
  4. ROSS J. D., HORNE N. W., GRANT I. W., CROFTON J. W. Hospital treatment of pulmonary tuberculosis; a follow-up study of patients admitted to Edinburgh hospitals in 1953. Br Med J. 1958 Feb 1;1(5065):237–242. doi: 10.1136/bmj.1.5065.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. SHAW J. B., WYNN-WILLIAMS N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc. 1954 May;69(5):724–732. doi: 10.1164/art.1954.69.5.724. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES